Level Biotechnology (3118)

Currency in TWD
32.15
-0.05(-0.16%)
Delayed Data·
3118 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
Fair Value
Day's Range
32.1532.35
52 wk Range
29.5034.70
Key Statistics
Bid/Ask
31.25 / 31.40
Prev. Close
33.25
Open
32.35
Day's Range
32.15-32.35
52 wk Range
29.5-34.7
Volume
5.19K
Average Volume (3m)
18.94K
1-Year Change
3.04%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
3118 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Pays a significant dividend to shareholders

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Level Biotechnology Company Profile

Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. It also markets and distributes biomedical precision equipment. In addition, the company provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. Further, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan.

Employees
132
Market
Taiwan

Compare 3118 to Peers and Sector

Metrics to compare
3118
Peers
Sector
Relationship
P/E Ratio
15.9x21.3x−0.5x
PEG Ratio
−32.020.060.00
Price/Book
1.8x1.2x2.6x
Price / LTM Sales
1.4x3.4x3.3x
Upside (Analyst Target)
-0.0%42.8%
Fair Value Upside
Unlock36.9%6.5%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.02%
Dividend Yield
5.59%
Industry Median 3.57%
Annualised payout
1.80
Paid annually
5-Years Growth
+6.72%
Growth Streak

Earnings

Latest Release
May 13, 2025
EPS / Forecast
0.61 / --
Revenue / Forecast
176.87M / --
EPS Revisions
Last 90 days

3118 Income Statement

FAQ

What Stock Exchange Does Level BioTech Trade On?

Level BioTech is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for Level BioTech?

The stock symbol for Level BioTech is "3118."

What Is the Level BioTech Market Cap?

As of today, Level BioTech market cap is 1.04B.

What Is Level BioTech's Earnings Per Share (TTM)?

The Level BioTech EPS (TTM) is 2.02.

From a Technical Analysis Perspective, Is 3118 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Level BioTech Stock Split?

Level BioTech has split 5 times.

How Many Employees Does Level BioTech Have?

Level BioTech has 132 employees.

What is the current trading status of Level BioTech (3118)?

As of 06 Aug 2025, Level BioTech (3118) is trading at a price of 32.15, with a previous close of 33.25. The stock has fluctuated within a day range of 32.15 to 32.35, while its 52-week range spans from 29.50 to 34.70.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.